This paper is in the following e-collection/theme issue:

Formative Studies and eHealth/mHealth Development (524) Non-randomized Protocols and Methods (ehealth) (567) Coronary Heart Disease (81)

Published on in Vol 7, No 1 (2018): January

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/8660, first published .
Motivational Interviewing and Medication Review in Coronary Heart Disease (MIMeRiC): Intervention Development and Protocol for the Process Evaluation

Motivational Interviewing and Medication Review in Coronary Heart Disease (MIMeRiC): Intervention Development and Protocol for the Process Evaluation

Motivational Interviewing and Medication Review in Coronary Heart Disease (MIMeRiC): Intervention Development and Protocol for the Process Evaluation

Authors of this article:

Malin Johansson Östbring1, 2 Author Orcid Image ;   Tommy Eriksson3, 4 Author Orcid Image ;   Göran Petersson2 Author Orcid Image ;   Lina Hellström1 Author Orcid Image
Article Authors Cited by (4) Tweetations (2) Metrics

Journals

  1. Croot L, O’Cathain A, Sworn K, Yardley L, Turner K, Duncan E, Hoddinott P. Developing interventions to improve health: a systematic mapping review of international practice between 2015 and 2016. Pilot and Feasibility Studies 2019;5(1) View
  2. Östbring M, Eriksson T, Petersson G, Hellström L. Motivational Interviewing and Medication Review in Coronary Heart Disease (MIMeRiC): Protocol for a Randomized Controlled Trial Investigating Effects on Clinical Outcomes, Adherence, and Quality of Life. JMIR Research Protocols 2018;7(2):e57 View
  3. Kempen T, Bertilsson M, Hadziosmanovic N, Lindner K, Melhus H, Nielsen E, Sulku J, Gillespie U. Effects of Hospital-Based Comprehensive Medication Reviews Including Postdischarge Follow-up on Older Patients’ Use of Health Care. JAMA Network Open 2021;4(4):e216303 View
  4. Östbring M, Eriksson T, Petersson G, Hellström L. Effects of a pharmaceutical care intervention on clinical outcomes and patient adherence in coronary heart disease: the MIMeRiC randomized controlled trial. BMC Cardiovascular Disorders 2021;21(1) View